I
g gene rearrangement during mammalian B cell development generally follows an ordered progression beginning with H chain genes, and proceeding to K and then X L chain genes (1) (2) (3) . The outcome of a functional rearrangement at both H and L chain loci is an immature B cell expressing a clonotypic cell surface Ig receptor. Functional rearrangements of H and L chain genes are probably essential for survival of most developing B cells, since surface Ig-B lineage cells with nonfunctional Ig gene rearrangements have never been found in secondary lymphoid tissues. Functional Ig gene rearrangements and subsequent differentiation of B cell precursors are regulated by recombination activating genes 1 and 2 (RAG-1 and -2) 1 (4), and external factors (e.g., cytokines and B cell precursor-stromal cell interactions) in the bone marrow microenvironment (5, 6) . A number of 1Abbreviations used in this paper: Pl, propidium iodide; RAG-l, recombination activating gene 1. studies have also suggested that/~ H chain proteins can regulate Ig gene rearrangement, through both suppression of continuing H chain gene rearrangement, and activation of L chain gene rearrangement (7, 8) .
Although the H chain --~ x L chain ~ ~ L chain hierarchy is the predominant rearrangement sequence during B cell development, exceptions have been described. For example, Kubagawa et al. (9) characterized four EBV-transformed human fetal bone marrow (FBM) pre-B cell lines that synthesized K L chains, but no # H chains. Two of the four had both H chain alleles in germline, indicating that H chain gene rearrangement and expression is not an absolute requirement for x L chain gene rearrangement and expression. Exceptions to the ~--~, hierarchy have also been reported. Several mouse cell lines have been described with functional S rearrangements and both x alleles in germline (10, 11) , as have rare cases of human leukemic cells with ~ rearrangements and germline ~ alleles (12, 13) .
We have developed a short-term culture that supports func-tional L chain gene rearrangement and differentiation of normal human pre-B cells in vitro (14) . As part of an effort to determine whether the conventional r -~ X rearrangement hierarchy was occurring in vitro, we generated EBV transformants from cultures undergoing pre-B cell differentiation. Several of these cell lines are shown to manifest patterns of L chain gene rearrangement and expression that have not been described in human B cell development. Evidence is presented that normal, nontransformed human B cells coexpressing cell surface r and X L chains exist in vivo.
Materials and Methods
Cells. Cells were isolated from 18-21-wk gestational age human fetal bone marrow in accordance with the guidelines of the University of Minnesota Committee on the Use of Human Subjects in Research. CD10 § Aurface L chain-B cell precursors were isolated by magnetic bead depletion as described in detail elsewhere (14, 15) . This enriched B cell precursor population (90-95% CD19 + cells) contained ,,~30% cytoplasmic/~-pro-B cells, and •70% cytoplasmic # + pre-B cells. After magnetic bead depletion, the cell viability was 99% as assessed by trypan blue exclusion. The enriched CD10 § L chain-cells were resuspended in RPMI-1640, 10% FCS, 100 U Penicillin/m1, and 100/~g streptomycin/ml (complete medium) at a concentration of 106 cdls/ml. They were immediately transformed with EBV (day 0) as described below, or incubated at 37~ 5% CO2 for 1 or 3 d before EBV transformation (day 1 or 3). Viability of the CD10+/surface L chain-cells cultured for 1-3 d was 66-84%. In some experiments, the entire fetal bone marrow B lineage population was isolated by leaving out the anti-/~ mAb in the magnetic bead depletion. These cells were used to determine whether B cells coexpressing r and X L chains exist (see below).
Fetal spleen cell suspensions were prepared by pressing small pieces of tissue through a sterile, stainless steel mesh. Mononuclear cells were isolated by Ficoll-Hypaque centrifugation, and the adherent cells were depleted by a 1-2-h incubation on plastic tissue culture flasks. T cells were then eliminated by magnetic bead depletion using anti-CD2 and -CD7 mAb. The resulting population was >95% CD19 +.
Antibodies. Hybridoma cells obtained from the American Type
Culture Collection (Rockville, MD) were used to produce murine mAb recognizing human /~ H chains (HB57), and r L chains (HB61). HB61 was directly conjugated to FITC for use in some experiments (16) . The mAb were purified from ascites using standard protein A-Sepharose chromatography (Pharmacia LKB Biotechnology, Piscataway, NJ). F(ab')2 goat anti-human r-FITC and F(ab')2 goat anti-human X-PE were used as a dual staining cocktail in two-color flow cytometry along with control F(ab')2 goat Ig conjugated to FITC and PE. These reagents were purchased from Tago Immunologicals (Burlingame, CA). Goat anti-human ~-FITC and goat anti-human X-tetramethyl-rhodamine isothiocyanate (TRITC) were purchased from Southern Biotechnology Associates, Inc. (Birmingham, AL), as were unconjugated and biotinylated mouse anti-human )~ (product 9180-01 and 9180-08) used in immunofluorescence and immunoprecipitation assays. Murine IgG1 myeloma protein (Cappel Products, Durham, NC) was FITC conjugated or biotinylated using standard methods (16) . Streptavidin-PE was purchased from Caltag Laboratories (South San Francisco, CA).
Iraraunofluorescent Stainin~ Flow Cytometry, and Fluorescence Microsco~. Cells were washed twice with fluorescence buffer (PBS, 2.5% newborn calf serum, 0.02% NAN3) and stained with F(ab')2 goat anti-human r-FITC and ~-PE for 20-30 min on ice. Controls consisted of F(ab')2 goat Ig conjugated to FITC or PE. An alternative staining protocol used mouse anti-human r-FITC and biotinylated mouse anti-human ~ plus streptavidin-PE. Controls in this protocol were mouse IgG1-FITC and biotinylated mouse IgG1. Cells were washed twice in fluorescence buffer and fixed in 1% paraformaldehyde before analysis on a FACScan | using Consort 30 software (Becton Dickinson & Co., Mountain View, CA). Some experiments incorporated propidium iodide (PI) (Sigma Chemical Co., St. Louis, MO) to electronically gate out nonspecific fluorescent staining of dead cells. Cells in these experiments were not fixed in paraformaldehyde. A FACStar ~ equipped with the FACStar PLUS | Pulse Processing Option (Becton Dickinson & Co.) was used to measure the pulse width of forward angle light scatter (17) , in order to formally exclude cell doublets from some analyses. Potential Fc receptor bound Ig was disassociated by washing the cells in pH 4.0 acetate buffer for 1 min at 4~ (18) .
Immunofluorescence microscopy was used to directly analyze normal B lineage cells for coexpression of cell surface r and ~, L chains. CD10 § fetal bone marrow B lineage cells (containing "~25% B cells expressing cell surface r and ),) were stained on ice for 30 min with saturating concentrations of goat anti-human r-FITC and goat anti-human ~-TRITC, washed three times in fluorescence buffer, and fixed in 1% paraformaldehyde. Fixed cells were cytocentrifuged onto microscope slides, and cell dots were mounted in one drop of 1 mg/ml p-phenylenediamene (Sigma Chemical Co.) in pH 8.0 glycerol. The slides were examined using a fluorescent microscope (Zeiss, Obercochen, Germany) equipped with ploem epiilumination and selective barrier filters to distinguish green and red fluorescence. ASA 400 film (Ektachrome; Eastman Kodak, Rochester, NY) was used for phase/fluorescent photomicrographs.
EBV Transformation and Culture
Conditions. CD10 +/surface L chain-calls were incubated at 37~ 5% COs for 3 d with EBV obtained from culture superuatants of the B95-8 marmoset cell line. Cells were then cultured in complete medium in 96-well microtiter plates (Costar, Cambridge, MA) containing 4,000 or 10,000 irradiated (6,000 rad) fetal bone marrow fibroblasts. Seeding densities ranged from 10 to 10 s B cell precursors/well. One half of the culture supernatant was replaced twice weekly with fresh complete medium. Stable EBV transformants emerged in 2-4 mo.
Southern Blotting. Ceils were digested at 37~ for 18 h in TNE (10 mM Tris, pH 8.0, 100 mM NaC1, and I mM EDTA, pH 8.0), 2 mg/ml proteinase K, and 1% SDS. DNA was extracted in "~6 M NaC1, and precipitated in 2 vol of cold absolute ethanol. Dry DNA pellets were dissolved in 50-100/~1 TE (10 mM Tris, pH 7.6 and 1 mM EDTA, pH 8.0), and digested with EcoRI, BamHI, or BamHI-HindlII (GIBCO BRL, Gaithersburg, MD) for 4-5 h at 37~ 2-10/~g of DNA were loaded per lane of a 0.6 or 0.8% agarose gel and electrophoresed in TBE (0.089 M Tris, 0.089 M boric add, and 0.002 M EDTA). Transfer of DNA to nylon membranes (GeneScreenPlus; NEN Research Products, Boston, MA) was facilitated by 10x SSC using vacuum blotting with PosiBlot | (Stratagene, La Jolla, CA) following the manufacturer's protocol. The membrane was dried at room temperature or UV crosslinked using 1,200,000 joules (UV crosslinker; Stratagene). Membranes were prehybridized in 10% dextran sulfate (Sigma Chemical Co.), 1% SDS, and 1 M NaCI. Hybridization was conducted at 65~ for 18 h with o~-~2[P]dCTP-labeled probes (see below). The membranes were washed sequentially with 2x SSC, 0.5% SDS at room temperature for 10 min; lx SSC, 0.5% SDS at 63~ for 15-30 min; and, when needed, 0.1x SSC, 0.5% SDS at 63~ for 15-30 min. Membranes were then exposed to a final wash with 2 x SSC at room temperature for 10 rain before autoradiography using X-Omat AP, film (Eastman Kodak) at -70~ Exposure times ranged from 3 to 5 d.
Probes were labded with cz-[32p]dCTP to sp act of ~2.0 x 109 dpm//~g using random sequence hexanudeotide primers in a DNA polymerase I (Klenow fragment) catalyzed reaction (19) , according to the manufacturer's recommendations (Multiprime DNA Labeling Systems; Amersham Corp., Arlington Heights, IL). Four probes were used to assess the status of the Ig genes; a 0.8-kb germline BamHI-HindIII fragment containing the Cxl gene (20), a 2.5-kb germline EcolLI CK probe (21), a 2.5-kb HindIII-BamHI fragment of the x deleting element (Kde) (22, 23) , and a 2.4-kb Sau3a genomic J. fragment (24) .
Biosynthetic Labeling, Immunoprecipitation, and SDS-PAGE. Log
phase cells were biosynthetically labeled for 3 h at 37~ with t-[3SS]cysteine (Amersham Corp.) as previously described (25) . Labeling was halted by three washes in cold PBS, and the cells were lysed in 0.1 M Tris (pH 8.1), 0.9% NaC1, 0.5% NP-40 (Particle Data Inc., Elmhurst, IL), 1 mM EDTA, 1% aprotinin, 1.0/~g/ml leupeptin, 0.7/~g/ml pepstatin, and 2 mM PMSF (Sigma Chemical Co.). Debris was pelleted by centrifugation at 10,000 g for 30 rain at 4~ Lysates from biosynthetically labeled cells were precleared twice (2 h and overnight) with 10% protein A-Sepharose CL-4B (Pharmacia LKB Biotechnology) at 4~ 50/~1 aliquots of precleared lysate were incubated with 25 #g of purified antibody for 3 h at 4~ Immune complexes were precipitated with 75/~1 of 10% protein A-Sepharose containing 1 mg/ml BSA for 1 h at 4~ and washed four times in lysis buffer containing 0.5% deoxycholate (Sigma Chemical Co.). Immune complexes were eluted, reduced in sample buffer (80 mM Tris, pH 6.8, 3% SDS, 15% glycerol, 0.01% bromophenol blue, and 5% 2-ME), and resolved on 13% SDS-PAGE gels. Gels were submerged in Amplify (Amersham Corp.) for 30 rain and visualized using Kodak X-Omat AlL film at -70~
Results

Characterization of In Vitro Differentiated Pre-B Cells
Rescued by EBV Transformation. We have described a short-term culture that supports functional L chain gene rearrangement and differentiation of normal human pre-B cells (14) . To determine whether the conventional x---X rearrangement hierarchy was occurring in vitro, we generated EBV transformants from cultures undergoing pre-B cell differentiation. CD10+Aur -face L chain-B cell precursors containing 60-70% pre-B ceUs were isolated from six donors and cultured for 1 or 3 d. As shown in Table 1 , L chain gene rearrangement and expression occurred in all six. Consistent with our previous findings (14),), expression predominated over K in four of the six cultures (Table 1) . EBV transformation of these six cultures, as well as fresh CD10+/surface L chain-cells isolated from three of the donors, culminated in the establishment of 143 cell lines. Two-color flow cytometric analysis revealed that 38 of the 143 cell lines expressed cell surface X L chains. 24 of these cell lines were clonal by Southern blotting utilizing J., C~, xde, and Cx probes. 21 of the 24 X-expressing donal cell lines had rearranged the K locus, as would be predicted from earlier studies (1) (2) (3) 26) . Of the 21, 15 had both K alleles deleted, three had one x aUde deleted and the other in germline, two had one g allele rearranged (Fig. 3) . The presence of a 29-kD X L chain (Fig. 3 ) also diminated the possibility that our results could be explained by the synthesis of surrogate X L chains, which have molec- (Fig. 8 B) . Only 0.9% of the ~+/X + events were PInegative doublets (top left quadrant). Similar analysis on two other donors, coupled with the donor in Fig. 8, revealed that only 0.53 -0.58% of the ~+/X + cells had pulse width profiles consistent with cell doublets. Importantly, analysis of the rare PI-negative doublets in the total B lineage population (Fig. 8 C, top left) revealed a random distribution amongst the x -I X -, K+/X -, K-IX + populations (Fig. 8  D) . Treatment of fetal bone marrow B cells with a pH 4.0 acetate buffer wash also had no effect on the coexpression of g and )~ L chains (data not shown). 
Identification of A-Expressing EBV-transformed Cell Lines That
Fetal Bone Marrow
Discussion
In a study published several years ago, we observed that normal human pre-B ceils that differentiate in vitro give rise to a higher percentage of immature B cells expressing surface /~/)x than surface/~/K (13). A possible explanation for this data is that some pre-B cells make functional ), rearrangements directly, and bypass x rearrangements altogether. Studies originally reported by Korsmeyer et al. (26) and Hieter et al. (32) suggested an ordered progression (hierarchy) of K'->)~ rearrangement in human B ceils, an observation consistent with studies in the mouse (for a review see reference 3). The K--*)~ hierarchy is, nonetheless, not absolute. Several mouse cell lines have been described with functional )~ rearrangements and both x alleles in germline (10, 11) , and analyses of human cells also suggest that )~ rearrangement can precede K (12, 13) . However, the studies of human cells did not resolve whether the )~ rearrangements gave rise to )~ L chains.
In the current study, EBV transformation was used to rescue the differentiated progeny of pre-B cells, and transformants expressing #/)~ surface Ig receptors were examined for their K gene rearrangement status. Using this approach, we produced and characterized two cell lines, designated 35.30 and 36.31, both containing functional )~ rearrangements with K alleles in germline. The germline status of the g alleles in both cell lines was confirmed by the absence of detectable rearrangements of the gde alleles. The H chain rearrangement profile was consistent with donality in both cell lines, and synthesis/expression of ;k L chains was directly demonstrated in 36.31 cells (Fig. 3) . These collective results provide direct evidence that nonleukemic human fetal bone marrow B lineage cells harbor the capacity to make functional )x L chain gene rearrangements without rearranging or deleting either x allele.
It is conceivable that 36.31 and 35.30 arose from fetal bone marrow B lineage cells containing germline X genes, and X rearrangements occurred after expansion of the EBVtransformed done in vitro. Yet, additional Ig gene rearrangements and isotype switching are rarely observed after EBV transformation (9, 33, 34) . Rearrangement of the Kde (or recombining sequence as it has been called in the mouse) has been proposed as a mechanism that serves to initiate )~ rearrangement (23, 35, 36) . However, studies comparing the Ig gene rearrangement status of short-versus long-term EBVtransformed cell lines (26, 32) , and studies done with a mufine myeloma (10) , suggest that deletion of Cx can occur after k rearrangement has been initiated. It is therefore possible that 36.31 and 35.30 represent cells rescued by EBV before rearranging or deleting one or both K alleles.
The notion that expression of a single L chain isotype is stringently imposed at the level of individual mature B cells, first demonstrated in human cells by Bernier and Cebra (37, 38) , is a widely accepted concept in immunology. Sporadic reports have appeared suggesting that exceptions to the single L chain isotype rule may exist in human B cells. Human myeloma cells coexpressing cytoplasmic x and )~ L chains have been described (39) (40) (41) , as has a single case of acute lymphoblastic leukemia (42) . However, none of these studies provided immunochemical evidence that the myeloma cells synthesized and expressed K and )~ L chains. The results presented in this report provide solid evidence that human B cells exist which coexpress g and )~ L chains on the surface of a single cell. The EBV-transformed cell line 30.30 provided the initial clue. Two-color flow cytometry revealed a major population of 30.30 cells coexpressing g and )~ L chains (Fig. 4) . Southern blotting revealed that 30.30 had a single H chain rearrangement, both K alleles rearranged, both gde alleles in germline, and one ~ rearrangement (Fig. 5) . Direct evidence that 30.30 cells synthesize and express g and )~ L chains was demonstrated by biosynthetic labeling and immunopredpitation/SDS-PAGE (Fig. 6) . Efforts to isolate a stable, pure population of 30.30 Fig. 4 . The constant presence of a ~,-population is in some discord with the immunoprecipitation data (Fig. 6) The establishment and characterization of the x+/X § 30.30 cell line prompted us to search for the existence of a normal in vivo counterpart. The data presented in Figs. 7-9 , provide strong evidence that x +/~+ human B ceils exist in fetal bone marrow and spleen. The possibility that the K § + population is an artifact attributable to dead cells, cell doublets, or passively (Fc receptor) adsorbed Ig was eliminated by propidium iodide gating to eliminate dead cells, pulse width analysis to eliminate cell doublets, and acid washing and 37~ incubation to eliminate potential passively adsorbed Ig. Most importantly, the flow cytometry data was confirmed by two-color immunofluorescence microscopy. The existence of K+/X + ceUs can be explained in several ways. Pre-B cells containing g and ~, in germline could simultaneously undergo functional Jc and ), V toJ rearrangements, giving rise to x +/X + cells. This developmental scenario would assume that the recombinase ensemble (e.g., RAG-1 and -2) would have equal access to the heptamer-nonamer recognition sequences in both x and )~ loci. Alternatively, #+/g+ or ~ +/X + B cells could rearrange the alternate L chain gene to give rise to ~+/X + cells. Independent of how ~+/~,+ cells arise, they may be transients during B cell ontogeny, in the process of switching L chain isotypes. The most likely pathway invoked by this model would be x--*gX--*X. In this pathway, the ultimate sole expression of )~ might occur after K deletion by the Kde. Support for a K-*xX--*X pathway can be found in the study by Gollahon et al. (43) , who observed ~, L chain expression in hybridomas generated from mice harboring a functionally rearranged K transgene. They also presented evidence that "~20% of X + normal splenic B cells coexpressed gL chain, and used this data to argue the existence of a so-called KX-B cell lineage which lacks feedback inhibition of L chain gene rearrangement (43) . Hardy et al. (44) also described a LPS-induced call surface K + murine Ly-1 + lymphoma that expressed cell surface ~ L chains. A X--*xX--*x pathway is also possible, since human B cells with functional ~ rearrangements and germline K alleles exist in the form of the 36.31 and 35.30 cell lines. Support for this pathway is weakened by the absence of a homologue to the xde in the ~, locus (45) .
Do Jc +/~ + cells subserve any function in the immune response? Cohn and Langman (46) have used the theoretical argument that "doubles" (including tc+/X + and cells expressing two alleles of the same L chain isotype) must exist to maintain the evolutionary selection pressure necessary for haplotype exclusion. B cells undergoing L chain isotype switching could also contribute to Ig repertoire diversification by (presumably) changing antigen specificity. Our identification of K+/X + B cells in normal fetal bone marrow and spleen, coupled with the recently described CD40/L cell system for growing normal human B cells in vitro (47) , may facilitate characterization of V. and VL usage, cytokine responsiveness, and antigen specificity in these unusual calls.
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